A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.
To improve the transparency of clinical trial generalizability and to illustrate the method using Type 2 diabetes as an example.
Author(s): Weng, C, Li, Y, Ryan, P, Zhang, Y, Liu, F, Gao, J, Bigger, J T, Hripcsak, G
DOI: 10.4338/ACI-2013-12-RA-0105